State of Wyoming’s OptimizeRx OPRX Stock Holding History

State of Wyoming’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,251	Closed	-$221K	–	2150
2026 Q1	$221K	Buy	35,251 +24,716	+235%	+$230K	0.03%	871
2025 Q4	$129K	Sell	10,535 -11,298	-52%	-$185K	0.01%	1216
2025 Q3	$448K	Buy	+21,833	New	+$346K	0.05%	378
2024 Q3	–	Sell	-7,513	Closed	-$75.1K	–	1843
2024 Q2	$75.1K	Buy	7,513 +2,090	+39%	+$23K	0.01%	1193
2024 Q1	$65.9K	Buy	5,423 +1,378	+34%	+$20K	0.01%	1208
2023 Q4	$57.9K	Buy	4,045 +1,567	+63%	+$15K	0.01%	1257
2023 Q3	$19.3K	Sell	2,478 -3,282	-57%	-$35.7K	﹤0.01%	1505
2023 Q2	$82.3K	Sell	5,760 -2,704	-32%	-$38.5K	0.02%	937
2023 Q1	$124K	Buy	+8,464	New	+$142K	0.04%	638

Other funds holding OPRX

PAWC

P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

McAdam LLC Philadelphia, Pennsylvania $2.59B AUM 21.24% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State of Wyoming's OPRX Position: Q2 2026 in Review

State of Wyoming sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 35,251 shares — an estimated $221K sold.

State of Wyoming first reported a position in OPRX in Q1 2023 and held it in 9 quarters. The position peaked at $448K in Q3 2025. 28 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

State of Wyoming reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
State of Wyoming sold 35,251 OptimizeRx shares in Q2 2026, an estimated $221K.
State of Wyoming first reported a position in OptimizeRx in Q1 2023 and held it in 9 quarters.
State of Wyoming's OptimizeRx position peaked at $448K in Q3 2025.
28 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.